Upgrade to SI Premium - Free Trial

Leerink Downgrades Fulcrum Therapeutics (FULC) to Market Perform

June 2, 2026 6:03 AM
(Updated - June 2, 2026 6:19 AM EDT)

Leerink analyst Joseph P. Schwartz downgraded Fulcrum Therapeutics (NASDAQ: FULC) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Downgrades